178 related articles for article (PubMed ID: 32484856)
1. Multiple mutations at exon 2 of RHOA detected in plasma from patients with peripheral T-cell lymphoma.
Ottolini B; Nawaz N; Trethewey CS; Mamand S; Allchin RL; Dillon R; Fields PA; Ahearne MJ; Wagner SD
Blood Adv; 2020 Jun; 4(11):2392-2403. PubMed ID: 32484856
[TBL] [Abstract][Full Text] [Related]
2. Droplet digital polymerase chain reaction assay and peptide nucleic acid-locked nucleic acid clamp method for RHOA mutation detection in angioimmunoblastic T-cell lymphoma.
Tanzima Nuhat S; Sakata-Yanagimoto M; Komori D; Hattori K; Suehara Y; Fukumoto K; Fujisawa M; Kusakabe M; Matsue K; Wakamatsu H; Shimadzu M; Chiba S
Cancer Sci; 2018 May; 109(5):1682-1689. PubMed ID: 29493850
[TBL] [Abstract][Full Text] [Related]
3. Early detection of T-cell lymphoma with T follicular helper phenotype by RHOA mutation analysis.
Dobson R; Du PY; Rásó-Barnett L; Yao WQ; Chen Z; Casa C; Ei-Daly H; Farkas L; Soilleux E; Wright P; Grant JW; Rodriguez-Justo M; Follows GA; Rashed H; Fabre M; Baxter EJ; Vassiliou G; Wotherspoon A; Attygalle AD; Liu H; Du MQ
Haematologica; 2022 Feb; 107(2):489-499. PubMed ID: 33567811
[TBL] [Abstract][Full Text] [Related]
4. Detection of the G17V RHOA mutation in angioimmunoblastic T-cell lymphoma and related lymphomas using quantitative allele-specific PCR.
Nakamoto-Matsubara R; Sakata-Yanagimoto M; Enami T; Yoshida K; Yanagimoto S; Shiozawa Y; Nanmoku T; Satomi K; Muto H; Obara N; Kato T; Kurita N; Yokoyama Y; Izutsu K; Ota Y; Sanada M; Shimizu S; Komeno T; Sato Y; Ito T; Kitabayashi I; Takeuchi K; Nakamura N; Ogawa S; Chiba S
PLoS One; 2014; 9(10):e109714. PubMed ID: 25310466
[TBL] [Abstract][Full Text] [Related]
5. Angioimmunoblastic T-cell Lymphomas With the RHOA p.Gly17Val Mutation Have Classic Clinical and Pathologic Features.
Ondrejka SL; Grzywacz B; Bodo J; Makishima H; Polprasert C; Said JW; Przychodzen B; Maciejewski JP; Hsi ED
Am J Surg Pathol; 2016 Mar; 40(3):335-41. PubMed ID: 26574844
[TBL] [Abstract][Full Text] [Related]
6. RHOA G17V mutation in angioimmunoblastic T-cell lymphoma: A potential biomarker for cytological assessment.
Lee PH; Weng SW; Liu TT; You HL; Liao CK; Wang MC; Huang WT
Exp Mol Pathol; 2019 Oct; 110():104294. PubMed ID: 31394087
[TBL] [Abstract][Full Text] [Related]
7. Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas.
Palomero T; Couronné L; Khiabanian H; Kim MY; Ambesi-Impiombato A; Perez-Garcia A; Carpenter Z; Abate F; Allegretta M; Haydu JE; Jiang X; Lossos IS; Nicolas C; Balbin M; Bastard C; Bhagat G; Piris MA; Campo E; Bernard OA; Rabadan R; Ferrando AA
Nat Genet; 2014 Feb; 46(2):166-70. PubMed ID: 24413734
[TBL] [Abstract][Full Text] [Related]
8. TET-2 mutations predict poor outcomes and are associated with unfavorable clinical-biological features in PTCL, not otherwise specified and angioimmunoblastic T-cell lymphoma in Brazilian patients.
de Pádua Covas Lage LA; Barreto GC; Culler HF; Cavalcante JB; de Oliveira Alves LB; Nardinelli L; Bendit I; Zerbini MCN; Rocha V; Pereira J
Cancer Biomark; 2022; 35(2):179-191. PubMed ID: 36093687
[TBL] [Abstract][Full Text] [Related]
9. RHOA mutation in follicular T-cell lymphoma: Clinicopathological analysis of 16 cases.
Miyoshi H; Sakata-Yanagimoto M; Shimono J; Yoshida N; Hattori K; Arakawa F; Yanagida E; Takeuchi M; Yamada K; Suzuki T; Moritsubo M; Furuta T; Chiba S; Ohshima K
Pathol Int; 2020 Sep; 70(9):653-660. PubMed ID: 32648273
[TBL] [Abstract][Full Text] [Related]
10. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma.
Sakata-Yanagimoto M; Enami T; Yoshida K; Shiraishi Y; Ishii R; Miyake Y; Muto H; Tsuyama N; Sato-Otsubo A; Okuno Y; Sakata S; Kamada Y; Nakamoto-Matsubara R; Tran NB; Izutsu K; Sato Y; Ohta Y; Furuta J; Shimizu S; Komeno T; Sato Y; Ito T; Noguchi M; Noguchi E; Sanada M; Chiba K; Tanaka H; Suzukawa K; Nanmoku T; Hasegawa Y; Nureki O; Miyano S; Nakamura N; Takeuchi K; Ogawa S; Chiba S
Nat Genet; 2014 Feb; 46(2):171-5. PubMed ID: 24413737
[TBL] [Abstract][Full Text] [Related]
11. The new biology of PTCL-NOS and AITL: current status and future clinical impact.
Timmins MA; Wagner SD; Ahearne MJ
Br J Haematol; 2020 Apr; 189(1):54-66. PubMed ID: 32064593
[TBL] [Abstract][Full Text] [Related]
12. Cardiac Tamponade as a Recurrence of Angioimmunoblastic T-Cell Lymphoma with the Detection of a p.Gly17Val RHOA Mutation in the Pericardial Effusion.
Tsuboi Y; Iimura Y; Matsumura F; Nanmoku T; Suma S; Matsuoka R; Nakagawa T; Nakagawa D; Suehara Y; Hattori K; Sato K; Maruyama Y; Sakamoto T; Yokoyama Y; Kato T; Kurita N; Nishikii H; Obara N; Ieda M; Chiba S; Sakata-Yanagimoto M
Intern Med; 2023 Feb; 62(4):595-600. PubMed ID: 35732446
[TBL] [Abstract][Full Text] [Related]
13. A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma.
Yoo HY; Sung MK; Lee SH; Kim S; Lee H; Park S; Kim SC; Lee B; Rho K; Lee JE; Cho KH; Kim W; Ju H; Kim J; Kim SJ; Kim WS; Lee S; Ko YH
Nat Genet; 2014 Apr; 46(4):371-5. PubMed ID: 24584070
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic Analysis of Angioimmunoblastic T-cell Lymphoma With or Without RHOA G17V Mutation Using Formalin-fixed Paraffin-embedded Sections.
Nagao R; Kikuti YY; Carreras J; Kikuchi T; Miyaoka M; Matsushita H; Kojima M; Ando K; Sakata-Yanagimoto M; Chiba S; Nakamura N
Am J Surg Pathol; 2016 Aug; 40(8):1041-50. PubMed ID: 27158755
[TBL] [Abstract][Full Text] [Related]
15. Angioimmunoblastic T-cell lymphoma-like lymphadenopathy in mice transgenic for human
Lee GJ; Jun Y; Yoo HY; Jeon YK; Lee D; Lee S; Kim J
Oncoimmunology; 2020 May; 9(1):1746553. PubMed ID: 32923110
[TBL] [Abstract][Full Text] [Related]
16. [Molecular diagnosis angioimmunoblastic T-cell lymphoma].
Chernova NG; Sidorova YV; Smirnova SY; Ryzhikova NV; Nikulina EE; Kovrigina AM; Sinitsyna MN; Sudarikov AB
Ter Arkh; 2019 Jul; 91(7):63-69. PubMed ID: 32598737
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive analysis of RHOA mutation positive and negative angioimmunoblastic T-cell lymphomas by targeted deep sequencing, expression profiling and single cell digital image analysis.
Butzmann A; Sridhar K; Jangam D; Kumar J; Sahoo MK; Shahmarvand N; Warnke R; Rangasamy E; Pinsky BA; Ohgami RS
Int J Mol Med; 2020 Oct; 46(4):1466-1476. PubMed ID: 32945366
[TBL] [Abstract][Full Text] [Related]
18. A Survey of Somatic Mutations in 41 Genes in a Cohort of T-Cell Lymphomas Identifies Frequent Mutations in Genes Involved in Epigenetic Modification.
Fernandez-Pol S; Ma L; Joshi RP; Arber DA
Appl Immunohistochem Mol Morphol; 2019 Jul; 27(6):416-422. PubMed ID: 29629950
[TBL] [Abstract][Full Text] [Related]
19. G17V RHOA: Genetic evidence of GTP-unbound RHOA playing a role in tumorigenesis in T cells.
Chiba S; Enami T; Ogawa S; Sakata-Yanagimoto M
Small GTPases; 2015; 6(2):100-3. PubMed ID: 26103434
[TBL] [Abstract][Full Text] [Related]
20. Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphoma.
Maura F; Agnelli L; Leongamornlert D; Bolli N; Chan WC; Dodero A; Carniti C; Heavican TB; Pellegrinelli A; Pruneri G; Butler A; Bhosle SG; Chiappella A; Di Rocco A; Zinzani PL; Zaja F; Piva R; Inghirami G; Wang W; Palomero T; Iqbal J; Neri A; Campbell PJ; Corradini P
Am J Hematol; 2019 Jun; 94(6):628-634. PubMed ID: 30829413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]